Valneva SE

French biotech vaccine company

Valneva SE ▸ Facts ▸ Comments ▸ News ▸ Videos

Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria, with other offices in France, Canada and the United States.

0 shares	Share Tweet Save Post Send

You Might Like

Phase-3 trials find 1-shot chikungunya vaccine safe, effective: Lancet The first chikungunya vaccine may be on its way with phase 3 trials of a single-shot jab developed by French biotech company Valneva showing the vaccine to be generally safe, well tolerated and.. IndiaTimes - Published on June 12, 2023
New COVID vaccine gets regulatory approval in UK A COVID vaccine developed by Valneva has been granted regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA). Sky News - Published on April 14, 2022
UK cancels deal with French firm for tens of millions of COVID jabs The UK has ended a vaccine supply deal for tens of millions of COVID-19 jabs with French company Valneva, the firm has said. Sky News - Published on September 13, 2021